Improving Lung Function in Severe Heterogenous Emphysema with the Spiration Valve System (EMPROVE). A Multicenter, Open-Label Randomized Controlled Clinical Trial

Overview of attention for article published in American Journal of Respiratory & Critical Care Medicine, December 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#17 of 15,247)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 88 news outlets
policy: 1 policy source
twitter: 42 X users

facebook: 1 Facebook page
guideline: 2 clinical guideline sources

Readers on

mendeley: 132 Mendeley

So far, Altmetric has seen 54 X posts from 42 X users, with an upper bound of 120,255 followers.

A study on one way to treat hyperinflation from emphysema #BIOE340 https://t.co/8AaS7pzaKB

Outstanding rvw of COPD by Dr. Josh Brotman included CRP-guided abx for COPD in PCP clinic ⬇️antibiotics (https://t.co/8E4EDBTqzR) and EMBROVE showed ⬆️ FEV1 and 6MWD with Spiration Valve System for with severe heterogeneous emphysema, but higher PTX (htt…

New2Trip: Improving Lung Function in Severe Heterogenous Emphysema w/ Spiration Valve System (EMPROVE). Multicenter, Open-Label Randomized Controlled Clinical Trial https://t.co/9pSGDt0j5Q

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 50 additional X posts.